Additionally, low-risk patients exhibited increased expression levels of most HLA genes, interleukin-2 (IL-2), and heightened activity in the M2-like tumor-associated macrophages (TAMs) pathway, as well as an elevated gene expression profile (GEP) score. The gene discussed is IL2; the disease is neoplasm.